Following the actions taken by Omega Pharma Invest NV to comply with the orders and request for information issued by the Commission de Surveillance du Secteur Financier (CSSF) in relation to some requirements of the law of 11 January 2008 on transparency requirements for issuers of securities, the CSSF has decided to lift the suspension of trading in the financial instruments issued by Omega Pharma Invest NV on the regulated market of the Luxembourg Stock Exchange.

In relation to the issuer’s failure to comply with some requirements of Article 3 of the Transparency Law, in relation to its management report and the statements made by the persons responsible within the issuer referred to in the CSSF's press release 15/57 dated 21 December 2015, additional documents have been stored and are available on the Luxembourg Officially Appointed Mechanism (www.bourse.lu).